Senior insider sale
Chief Accounting Officer at NEWAMSTERDAM PHARMA CO N.V. — senior position signals high conviction
$413.8K
16.54K shares
What this filing means
KOOIJ LOUISE FREDERIKA plans to sell 16.54K shares of NEWAMSTERDAM PHARMA CO N.V. valued at approximately $413.8K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/27/2025ACC: 0002004379-25-000002
Officer· Chief Accounting Officer
Since Jan 2026
16.54K
Shares to sell
$413.8K
Approx. market value
8.27K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
RSU Vesting
N/A
3/26/2025
8.27KTotal acquired8.27K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/26/2025 | RSU Vesting N/A | 8.27K | — |
| Total | 8.27K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
8.27K
Market value
$205.5K
8/25/2025
Planned — Approximate Date
Nasdaq Global MarketPlanned
Units to sell
8.27K
Market value
$208.3K
8/25/2025
Total
Units
16.54K
Value
$413.8K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/25/2025 | 8.27K | $205.5K | — | Completed |
| Planned — Approximate Date | ||||
8/25/2025 | 8.27K | $208.3K | Nasdaq Global Market | Planned |
| Total | 16.54K | $413.8K | ||